(Q40561102)

21 September 2017

title

Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial (English)

1 reference

21 September 2017

main subject

endometrial hyperplasia

1 reference

3

Bruce A Lessey

1 reference

21 September 2017

Michael J. Murray

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501608

12 March 2024

William R. Meyer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501608

12 March 2024

Richard H. Oi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501608

12 March 2024

Rebecca E. DeWire

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501608

12 March 2024

Marc A. Fritz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501608

12 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

full work available at URL

21 September 2017

https://journals.lww.com/10.1097/01.GME.0000063567.84134.D1

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

12 March 2024

1 reference

21 September 2017

volume

10

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

456-464

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Postmenopausal hormone therapy and mortality.

12 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

12 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

12 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys

12 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

12 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

12 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

AHA Science Advisory: Soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AHA

12 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

12 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins

12 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women

12 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans.

12 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women.

12 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

The effect of dietary soy supplementation on hot flushes

12 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment

12 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Purified phytoestrogens in postmenopausal bone health: is there a role for genistein?

12 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study

12 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys

12 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Interactive effects of soy protein and estradiol on coronary artery reactivity in atherosclerotic, ovariectomized monkeys

12 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Effects of mammalian and plant estrogens on mammary glands and uteri of macaques

12 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice

12 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin

12 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Comparative epidemiology of cancer between the United States and Japan. A second look

12 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Phytoestrogens and healthy aging: gaps in knowledge. A workshop report

12 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women

12 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai

12 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Dietary intake and sources of isoflavones among Japanese

12 March 2024

35

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Soy product intake and hot flashes in Japanese women: results from a community-based prospective study

12 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Dietary soy and cardiovascular disease risk

12 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study

12 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women

12 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Clinical effects of a standardized soy extract in postmenopausal women: a pilot study.

12 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism.

12 March 2024

43

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium

12 March 2024

44

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism

12 March 2024

46

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements

12 March 2024

47

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys

12 March 2024

48

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Ipriflavone in the Treatment of Postmenopausal OsteoporosisA Randomized Controlled Trial

12 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

A double-blind randomized study on the effects of red clover isoflavones on the endometrium

12 March 2024

50

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Soy isoflavones exert modest hormonal effects in premenopausal women

12 March 2024

51

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women

12 March 2024

52

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Treatment of bone loss in oophorectomized women with a combination of ipriflavone and conjugated equine estrogen

12 March 2024

53

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries

12 March 2024

55

1 reference

https://api.crossref.org/works/10.1097/01.GME.0000063567.84134.D1

12 March 2024

Identifiers

1 reference

21 September 2017

1 reference